The round was led by Georgetown Equity Partners, with participation from existing investors FCA Venture Partners, Distributed Ventures, and WVV. New investors include SteelSky Ventures, the largest women's health fund, as well as Scrub Capital and other digital health leaders.

Posterity Health is the leader in male reproductive and hormonal health. The company provides innovative solutions to address fertility challenges, optimize hormone levels, provide vasectomies and vasectomy reversals, and manage long-term health risks, combining cutting-edge technology with expert clinical care. Through their telehealth services, at-home diagnostics, and in-person care, Posterity Health is the trusted partner for men at every stage.